p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling

Andrei V Budanov1, Michael Karin

  • 1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, MC0723, La Jolla, CA 92093, USA.

Cell
|August 12, 2008
PubMed

Insights

The tumor suppressor p53, activated by stress, uses Sestrins to inhibit mTOR signaling. This research clarifies how p53 controls cell growth via the AMPK-TSC2-mTOR pathway, revealing a crucial link for cancer research.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncology

Background:

  • The tumor suppressor p53 regulates cell proliferation and growth in response to stress.
  • Mammalian target of rapamycin (mTOR) positively regulates cell growth and is inhibited by the TSC1:TSC2 complex.
  • The precise mechanism linking p53-mediated genotoxic stress response to mTOR inhibition was previously unclear.

Purpose of the Study:

  • To elucidate the mechanism by which p53-activated genes link genotoxic stress to mTOR signaling inhibition.
  • To investigate the role of Sestrin1 and Sestrin2 in this pathway.

Main Methods:

  • Analysis of p53 target genes Sestrin1 and Sestrin2.
  • Investigation of AMP-responsive protein kinase (AMPK) activation and its downstream effects.
  • Assessment of TSC2 phosphorylation and GTPase-activating protein (GAP) activity.
  • Utilizing Sestrin2-deficient mice to study mTOR signaling in vivo.

Main Results:

  • Sestrin1 and Sestrin2 activate AMPK.
  • Activated AMPK phosphorylates TSC2, enhancing its GAP activity and inhibiting mTOR.
  • Sestrin2-deficient mice exhibit impaired mTOR inhibition following genotoxic stress.
  • Sestrin1 and Sestrin2 establish a link between p53, genotoxic stress, and mTOR signaling.

Conclusions:

  • Sestrin1 and Sestrin2 are key mediators linking p53 activation during genotoxic stress to the inhibition of mTOR signaling.
  • This pathway represents a critical mechanism for controlling cell proliferation and growth under stress conditions.
  • Understanding this link has implications for developing novel cancer therapies targeting cell growth pathways.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...